Please login to the form below

Not currently logged in
Email:
Password:

Obizur

This page shows the latest Obizur news and features for those working in and with pharma, biotech and healthcare.

NHS England says yes to Roche's Hemlibra

NHS England says yes to Roche's Hemlibra

Among the treatments and interventions listed in the latest review at 'Level 2' were Shire’s Obizur (susoctocog alfa) for patients with acquired haemophilia A (a rare form of the disease)

Latest news

  • Shire and Baxalta drugs among CHMP's latest recommendations Shire and Baxalta drugs among CHMP's latest recommendations

    The EMA advisers backed Shire's Intuniv (guanfacine) and Obizur (susoctocog alfa) from Baxalta for European approval. ... Baxalta's Obizur for the treatment of bleeding episodes in patients with acquired haemophilia caused by antibodies to factor VIII.

  • Baxter haemophilia drug clears phase III trial Baxter haemophilia drug clears phase III trial

    It added to its portfolio last October after getting a US green light for Obizur for acquired haemophilia A, a rare and life-threatening form of the bleeding disorder.

  • FDA approves Baxter drug for rare form of haemophilia FDA approves Baxter drug for rare form of haemophilia

    Obizur is derived from pig proteins. Baxter has won US approval for its new drug to treat bleeding in a rare form of haemophilia. ... The US FDA last week approved Obizur in adults with acquired haemophilia A, a rare and life-threatening form of the

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics